Loading...
•
Jun 30, 2022
ICU Medical Q2 2022 Earnings Report
Announced second quarter 2022 results and updated FY 2022 guidance.
Key Takeaways
ICU Medical's second quarter 2022 revenue was $561.0 million, compared to $321.7 million in the same period last year. GAAP net loss for the second quarter of 2022 was $(7.5) million, or $(0.31) per diluted share. The company updated its full year 2022 guidance of adjusted EBITDA from a range of $450 million to $500 million to a range of $350 million to $370 million and adjusted diluted earnings per share from a range of $9.00 to $10.50 to a range of $6.20 to $6.80.
Second quarter 2022 revenue was $561.0 million, compared to $321.7 million in the same period last year.
GAAP gross profit for the second quarter of 2022 was $167.6 million, as compared to $123.5 million in the same period last year.
GAAP net loss for the second quarter of 2022 was $(7.5) million, or $(0.31) per diluted share, as compared to GAAP net income of 28.4 million, or $1.31 per diluted share, for the second quarter of 2021.
Adjusted diluted earnings per share for the second quarter of 2022 was $1.37 as compared to $1.88 for the second quarter of 2021.
Revenue by Segment
Forward Guidance
The Company is updating its full year 2022 guidance of adjusted EBITDA from a range of $450 million to $500 million to a range of $350 million to $370 million and adjusted diluted earnings per share from a range of $9.00 to $10.50 to a range of $6.20 to $6.80.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...